Skip to main content

Market Overview

12 Health Care Stocks Moving In Monday's Intraday Session

Share:

 

Gainers

  • Second Sight Medical (NASDAQ:EYES) stock rose 96.45% to $11.38 during Monday's regular session. Second Sight Medical's stock is trading at a volume of 229.5 million shares as of 12:32 EST. This is 1643.19% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $264.0 million.
  • OpGen (NASDAQ:OPGN) stock rose 76.47% to $3.46. As of 12:32 EST, this security is trading at a volume of 247.9 million shares, making up 6747.71% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $96.4 million.
  • Anchiano Therapeutics (NASDAQ:ANCN) shares rose 64.37% to $5.49. Anchiano Therapeutics's stock is trading at a volume of 43.2 million shares as of 12:32 EST. This is 1527.77% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $40.7 million.
  • Jaguar Health (NASDAQ:JAGX) shares rose 42.58% to $2.28. Jaguar Health's stock is trading at a volume of 46.2 million shares as of 12:32 EST. This is 81.64% of its average full-day volume over the last 100 days. The company's market cap stands at $268.7 million.
  • Idera Pharmaceuticals (NASDAQ:IDRA) shares moved upwards by 28.36% to $5.34. Trading volume for Idera Pharmaceuticals's stock is 1.2 million as of 12:32 EST. This is 249.43% of its average full-day volume over the last 100 days. The company's market cap stands at $225.6 million.
  • AEterna Zentaris (NASDAQ:AEZS) stock rose 22.82% to $1.13. Trading volume for this security as of 12:32 EST is 7.1 million, which is 41.9% of its average full-day volume over the last 100 days. The company's market cap stands at $131.3 million.

 

 

Losers

 

  • Soleno Therapeutics (NASDAQ:SLNO) shares fell 45.35% to $1.47 during Monday's regular session. Trading volume for this security as of 12:32 EST is 7.7 million, which is 2359.62% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $117.2 million. As per the news, the Q4 earnings report came out 3 days ago.
  • AnaptysBio (NASDAQ:ANAB) stock declined by 34.85% to $19.2. Trading volume for AnaptysBio's stock is 4.7 million as of 12:32 EST. This is 1311.22% of its average full-day volume over the last 100 days. The company's market cap stands at $525.4 million.
  • XTL Biopharmaceuticals (NASDAQ:XTLB) stock decreased by 11.72% to $3.31. As of 12:32 EST, XTL Biopharmaceuticals's stock is trading at a volume of 496.9K, which is 182.84% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.0 million.
  • Taysha Gene Therapies (NASDAQ:TSHA) stock declined by 9.64% to $26.53. Trading volume for Taysha Gene Therapies's stock is 16.8K as of 12:32 EST. This is 14.09% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion. As per the news, the Q4 earnings report came out 3 days ago.
  • Rubius Therapeutics (NASDAQ:RUBY) stock fell 9.16% to $11.41. Rubius Therapeutics's stock is trading at a volume of 315.3K shares as of 12:32 EST. This is 21.22% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $926.2 million.
  • Immunocore Holdings (NASDAQ:IMCR) stock declined by 8.5% to $37.52. Immunocore Holdings's stock is trading at a volume of 23.1K shares as of 12:32 EST. This is 7.58% of its average full-day volume over the last 100 days.

 

 

 

Related Articles (AEZS + ANAB)

View Comments and Join the Discussion!

Posted-In: BZI-TFMIntraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com